Product Details
Humira (adalimumab) 40 mg/0.4 mL Injection In Pakistan
Humira 40mg/0.4ml Injection contains adalimumab, a recombinant human monoclonal antibody and tumor necrosis factor (TNF) blocker. It works by binding to TNF-α, a protein involved in inflammation, thereby helping reduce abnormal inflammatory activity in the body.
Humira is used for several approved inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and certain forms of uveitis, depending on the patient's age and medical condition.
The 40mg/0.4ml presentation is supplied as a sterile, preservative-free solution intended for subcutaneous injection.
Benefits
- Contains adalimumab 40mg.
- Helps reduce inflammation associated with TNF-mediated diseases.
- Used for several chronic inflammatory and autoimmune conditions.
- May help reduce disease signs and symptoms when prescribed appropriately.
- Convenient 40mg/0.4ml subcutaneous injection presentation.
- Available in prefilled syringe or pen presentations, depending on the specific pack.
- Can be used as part of a long-term treatment plan under specialist medical supervision.
Specifications
| Specification | Details |
|---|---|
| Brand | Humira |
| Active Ingredient | Adalimumab |
| Strength | 40mg/0.4ml |
| Concentration | 100mg/ml |
| Dosage Form | Injection |
| Route | Subcutaneous |
| Drug Class | TNF Blocker |
| Type | Recombinant Human Monoclonal Antibody |
| Presentation | Prefilled Pen / Prefilled Syringe |
| Volume | 0.4ml |
| Manufacturer | AbbVie |
| Prescription Status | Prescription Medicine |
Each 40mg/0.4ml prefilled syringe or pen delivers 40mg of adalimumab in 0.4ml.
How To Use
Humira should be used exactly according to the prescription provided by your doctor. It is administered by subcutaneous injection, usually into areas such as the thigh or abdomen, with injection sites rotated as advised by your healthcare professional.
The dosage and frequency depend on the condition being treated, age, body weight where applicable, and individual response. Some treatment regimens use 40mg every other week, while other conditions may require different initial or maintenance schedules. Do not determine or change your dose yourself.
Before starting treatment, doctors generally evaluate patients for infections, including tuberculosis, and may consider hepatitis B risk. Humira can increase the risk of serious infections because it suppresses part of the immune system.
Do not use Humira if you have an active serious infection unless specifically directed by your healthcare professional. Live vaccines should generally be avoided during treatment unless your doctor advises otherwise.
Why Choose Humira?
Humira is an established adalimumab TNF-blocking therapy with approved uses across multiple inflammatory diseases. Its targeted mechanism can help control inflammation in patients for whom anti-TNF treatment is clinically appropriate.
The 40mg/0.4ml citrate-free formulation provides a concentrated, convenient presentation for subcutaneous administration and is available in user-friendly prefilled delivery devices.
